According to the Qichacha app, recently, Shaanxi Ginwa Enterprise(Group) Inc. has established Jinhua Nairuite Pharmaceutical Technology Co., Ltd. with Xing Boyue as the legal representative. The registered capital is 18 million yuan, and the scope of business includes: medical research and experimental development; sales of special medical purpose formula food; health consulting services (excluding diagnostic services); production of traditional Chinese medicine extracts; beverage production; pharmaceutical import and export. According to the equity penetration shown in Qichacha, the company is jointly held by Ginwa Enterprise(Group) Inc. and others.
金花股份等投资成立医药科技公司 含健康咨询服务业务
Ginwa Enterprise(Group) Inc. and other investors have established a pharmaceutical technology company, including health consulting services.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated